Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

NCT00575003 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Perennial Allergy to House Dust Mite and/or Cat

Interventions

DRUG: CYT003-QbG10

Sponsor

Cytos Biotechnology AG